Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Ph+ ALL, A Systematic Review.

Warraich, Z.; Tenneti, Pavan; Thai, T.; Hubben, Anne; Amin, H.; McBride, A.; Warraich, S.; Hannan, Abdul; Warraich, F.; Majhail, N.; Kalaycio, M.; Anwer, F.

doi:10.1016/j.bbmt.2019.09.022

Public

Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Ph+ ALL, A Systematic Review.

Shared by NobleBlocks on Mar 1, 2020 • 12:00 AM UTC

Authors:

Z. Warraich

Pavan Tenneti

T. Thai

Abstract

BACKGROUND Relapse after stem cell transplantation for Philadelphia chromosome (Ph) positive acute lymphoblastic leukemia (ALL) remains a significant challenge. In this systematic review, we compare survival outcomes of second-generation tyrosine kinase inhibitors (TKIs) nilotinib and dasatinib with...

Subject

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!